Relief Therapeutics Holding AG (RLF) — Strategic Asset Allocation Index
Relief Therapeutics Holding AG (RLF) has a Strategic Asset Allocation Index of 3.4% as of June 2023. Strategic assets (PP&E of CHF3.22 Million plus long-term investments of CHF-) total CHF3.22 Million, measured against net assets of CHF94.37 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Relief Therapeutics Holding AG Strategic Asset Allocation Index (2016–2021)
This chart shows how Relief Therapeutics Holding AG's Strategic Asset Allocation Index has evolved across 4 annual periods from 2016 to 2021. As of June 2023, the index stands at 3.4%, representing strategic assets of CHF3.22 Million against net assets of CHF94.37 Million CHF. Explore RLF cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Relief Therapeutics Holding AG (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Relief Therapeutics Holding AG from 2016 to 2021, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see RLF stock market capitalisation.
| Year | SAAI | Strategic Assets (CHF) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 1.4% | CHF2.54 Million | CHF2.54 Million | CHF- | CHF181.53 Million | ▲ +1.4 pp |
| 2018 | 0.0% | CHF1.00K | CHF1.00K | CHF- | CHF21.28 Million | ▼ 0.0 pp |
| 2017 | 0.0% | CHF5.00K | CHF5.00K | CHF- | CHF20.95 Million | ▼ 0.0 pp |
| 2016 | 0.0% | CHF8.00K | CHF8.00K | CHF- | CHF22.24 Million | — |